Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Studies how food, gut bacteria and genes affect blood sugar in type 1 diabetes

Observes how diet, gut microbes and genes shape blood sugar after meals in adults.

Plain-language title generated from the registry record
Registry title: Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes

Key facts

Where
Naples, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Source: NCT05936242, who can take part

Where in Italy

  • Federico II University HospitalNaples, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Federico II University
Trial code
NCT05936242
Record updated
19 September 2025
Original description
The goal of this observational study is to explore inter- and intra-individual determinants of postprandial glucose response in patients with type 1 diabetes using continous glucose monitoring (CGM).Read full original descriptionShow less

Evaluation of the INteraction Between Diet, microbiomE and Epigenetic Towards Personalized Interventions in Type 1 Diabetes (IN-DEEP Study)

The goal of this observational study is to explore inter- and intra-individual determinants of postprandial glucose response in patients with type 1 diabetes using continous glucose monitoring (CGM).

Blood samples and anthropometrics will be collected during hospital visit. Participants will be asked to:

* record a seven-day food diary * complete EPIC food frequency questionnaire * complete questionnaires on sleep hygiene * collect a stool sample

Inclusion: Type 1 Diabetes.

Exclusion: Other chronic or acute diseases; Pregnancy and/or breastfeeding; Use of antibiotics in the past 3 months.

ClinicalTrials.gov NCT05936242